China Animal Healthcare (EP4.SG) is off 4.2% at a month-low of 23 cents despite robust December-quarter results. “People are selling on news. The results are quite actually decent,” a dealer with a local brokerage told Dow Jones Newswires.
Despite the absence of buying interest, the animal drug maker’s prospects look firm as company has been actively acquiring companies to boost its portfolio amid increasing demand from farmers in China to vaccinate animals.
